Sponsor study identifier
observational
20
1 country
1
Study Start
August 1, 2024
Actual (reported)Primary Completion
September 1, 2024
Actual (reported)Study Completion
September 1, 2024
Actual (reported)Cerebral palsy (CP) is a neurodevelopmental disorder characterized by abnormalities in muscle tone, movement, and motor skills resulting from permanent, non-progressive damage to the developing brain before, during, or after birth. The worldwide prevalence of CP is 2-3 per 1000 live births. Spastic CP accounts for approximately 85% of all CP cases. Among the types of spastic CP, quadriparetic CP (QCP) is the most severe and accounts for 20% of spastic CP cases. Individuals diagnosed with quadriparetic cerebral palsy (QCP) are restricted from participating in daily life activities due to inadequate upper extremity function (spasticity, muscle weakness, inability to perform isolated movements, and limitation of supination movements). In order to correctly evaluate children diagnosed with QCP and determine treatment priorities, it is very important to evaluate them based on the International Classification of Functioning, Disability, and Health (ICF). In the literature, there is no study that evaluates the upper extremity of individuals with isolated QCP based on ICF. The aim of this study is to examine the upper extremity functions of individuals with isolated QCP diagnosis within the framework of ICF.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 1, 2024
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 1, 2024
Actual (reported)September 1, 2024
Actual (reported)September 1, 2024
Actual (reported)September 3, 2024
Actual (reported)September 5, 2024
Actual (reported)Modified Ashworth Scale (MAS)
It is a 6-point scale that measures the resistance of the muscle to passive movement by passively moving it through the normal range of motion of the joint. Within the scope of the study, the upper extremity muscles; shoulder flexors, shoulder extensors, elbow flexors, elbow extensors, forearm pronators, wrist flexors, wrist extensors, and fingers will be evaluated with MAS.
baseline
Manual Ability Classification System (MACS)
It is used to classify how children with CP use their hands to handle objects in daily activities. The MACS identifies 5 levels. The MACS levels are functional descriptions based on a child's usual, self-initiated ability to handle objects in daily activities. The levels are based on children's ability to handle objects independently and their need for assistance or adaptations to perform manual activities in daily life.
baseline
Functional Independence Measure for Children (WeeFIM)
It was developed to assess the functional independence levels of children with developmental disabilities in their daily living activities. The scale consists of 6 sections: self-care (6 items), sphincter control (2 items), transfers (3 items), movement (2 items), communication (2 items), and social and cognitive status (3 items). There are a total of 18 items in the sections. All items in the sections are scored from 1 to 7. 1 point indicates full dependency; 7 points indicate full independence. A total of 18 (full dependency) points and a maximum of 126 (full independence) points can be obtained.
Within the framework of ICF, the Modified Ashworth Scale, the Manual Ability Classification System and the Functional Independence Measure for Children will be applied to 20 quadriparetic children with CP.
Within the framework of ICF, the Modified Ashworth Scale, the Manual Ability Classification System and the Functional Independence Measure for Children will be applied to 20 quadriparetic children with CP.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Twenty quadriparetic children with CP, aged 0-17 years, will be included in the study for upper extremity evaluation.
Acıbadem Altunizade Hospital
Istanbul, AA, 34662, Turkey (Türkiye)
Neslihan Yıldızdağı
Acıbadem Atunizade Hospital
20 participants (actual enrollment reported by the registry).
First Submitted
September 3, 2024
First Posted
September 5, 2024
Study Start
August 1, 2024
Actual (reported)baseline
Contact the study team to confirm eligibility.
Primary Completion
September 1, 2024
Actual (reported)Study Completion
September 1, 2024
Actual (reported)Last Updated
September 19, 2024
Record last verified: 2024-09
Individual participant data will not be made available to other researchers.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: